B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CA5A

MOLECULAR TARGET

carbonic anhydrase 5A

UniProt: P35218NCBI Gene: 76335 compounds

CA5A (carbonic anhydrase 5A) is targeted by 35 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CA5A

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Zonisamide2.4010
2Indapamide1.956
3Chlorthalidone1.614
4Histamine1.614
5benzolamide1.393
6Furosemide1.393
7Histidine1.102
8Bumetanide1.102
9Celecoxib1.102
10Vanillic Acid1.102
11Metolazone1.102
12stx641.102
13Tryptophan1.102
14caffeic acid0.691
15Catechin0.691
16Folic Acid0.691
17Tyrosine0.691
18Quercetin0.691
19Resveratrol0.691
20Spermidine0.691
21Tyrosine0.691
22Bortezomib0.691
23Famotidine0.691
24Hydrochloric Acid0.691
25Hydrogen Cyanide Hydrogen cyanide (HCN);0.691
26hydrogen iodide0.691
27Hydrogen Sulfide0.691
28Hydrogen Sulfide0.691
29Lacosamide0.691
30Levodopa0.691
31Nitric Acid Nitric acid (HNO3).0.691
32Spermine0.691
33Sulfides Chemical groups containing0.691
34Sulpiride0.691
35tyrosol0.691

About CA5A as a Drug Target

CA5A (carbonic anhydrase 5A) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 35 compounds with documented CA5A interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CA5A inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.